Article
Delivering an accredited non‐invasive prenatal diagnosis service for monogenic disorders and recommendations for best practice
20 Dec 2017
Abstract excerpt
The identification of cell-free fetal DNA circulating in maternal blood combined with technological developments, in particular next-generation sequencing, is enabling the development of safer prenatal diagnosis. While this technology has been widely applied as a highly sensitive screening test for aneuploidy, there has been relatively little clinical application for the diagnosis of monogenic disorders. In the...
Topics
Join the communities discussing this publication.